These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8558026)

  • 21. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB; Smith CA; Graham CM
    J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
    Matsuo M; Wada H; Honda S; Tawara I; Uenaka A; Kanematsu T; Nakayama E
    J Immunol; 1999 Jun; 162(11):6420-5. PubMed ID: 10352255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive selection of gamma delta CTL by TL antigen expressed in the thymus.
    Tsujimura K; Takahashi T; Morita A; Hasegawa-Nishiwaki H; Iwase S; Obata Y
    J Exp Med; 1996 Dec; 184(6):2175-84. PubMed ID: 8976173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural analysis of thymus-leukemia (TL) antigens in the mouse.
    McIntyre KR; Hämmerling U; Uhr JW; Vitetta ES
    J Immunol; 1982 Apr; 128(4):1712-7. PubMed ID: 7061847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum requirements for in vivo modulation of thymus-leukemia antigens on mouse leukemia cells and thymocytes.
    Stackpole CW
    J Natl Cancer Inst; 1979 Jun; 62(6):1529-36. PubMed ID: 312352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells.
    Morita A; Takahashi T; Stockert E; Nakayama E; Tsuji T; Matsudaira Y; Old LJ; Obata Y
    J Exp Med; 1994 Mar; 179(3):777-84. PubMed ID: 8113675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement sensitivity of somatic hybrids of a complement-resistant murine leukemia cell line.
    Liang W; Cohen EP
    J Natl Cancer Inst; 1975 Aug; 55(2):309-17. PubMed ID: 51086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoregulatory changes induced by total lymphoid irradiation (TLI). I. Appearance of a population of cells bearing the thymus leukemia (TL) surface antigen in the lymph nodes and spleen.
    King DP; Strober S; Kaplan HS
    J Immunol; 1981 Sep; 127(3):1085-9. PubMed ID: 6973579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biochemical genetics of TL antigens on mouse thymocytes.
    Michaelson J; Tung JS; Flaherty L; Hämmerling U; Bushkin Y
    Eur J Immunol; 1982 Apr; 12(4):257-61. PubMed ID: 6980119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of a TL(+) murine leukemia cell line that resists the cytotoxic effects of guinea pig complement and specific antiserum.
    Yu A; Liang W; Cohen EP
    J Natl Cancer Inst; 1975 Aug; 55(2):299-308. PubMed ID: 51085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptation of membrane-associated determinants is an outgrowth of their metabolism.
    Cohen EP
    Prog Clin Biol Res; 1980; 42():145-68. PubMed ID: 6248890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the thymus leukemia (TL) product encoded by the BALB/c T3c gene by DNA-mediated gene transfer. Comparison to the T13c product and BALB/c leukemia TL.
    Chorney MJ; Mashimo H; Bushkin Y; Nathenson SG
    J Immunol; 1989 Dec; 143(11):3762-8. PubMed ID: 2584718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonclassical behavior of the thymus leukemia antigen: peptide transporter-independent expression of a nonclassical class I molecule.
    Holcombe HR; Castaño AR; Cheroutre H; Teitell M; Maher JK; Peterson PA; Kronenberg M
    J Exp Med; 1995 Apr; 181(4):1433-43. PubMed ID: 7699328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor-specific antigen.
    Tsujimura K; Obata Y; Takahashi T
    Cancer Sci; 2004 Jun; 95(6):469-74. PubMed ID: 15182425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer immunology: the search for specificity.
    Old LJ
    Natl Cancer Inst Monogr; 1982; 60():193-209. PubMed ID: 6181408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly restricted expression of the thymus leukemia antigens on intestinal epithelial cells.
    Wu M; van Kaer L; Itohara S; Tonegawa S
    J Exp Med; 1991 Jul; 174(1):213-8. PubMed ID: 1711563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural identity of the TL antigen homologues derived from strain 2 and strain 13 guinea pigs.
    Surratt RS; Abruzzini LN; Zacheis MP; Cigen R; Schwartz BD
    J Immunol; 1983 Sep; 131(3):1344-9. PubMed ID: 6604095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of TL, H-2, and chimeric H-2/TL genes in transgenic mice: abnormal thymic differentiation and T-cell lymphomas in a TL transgenic strain.
    Hamasima N; Takahashi T; Taguchi O; Nishizuka Y; Stockert E; Old LJ; Obata Y
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7995-9. PubMed ID: 2813374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The binding of thymus leukemia (TL) antigen tetramers to normal intestinal intraepithelial lymphocytes and thymocytes.
    Tsujimura K; Obata Y; Matsudaira Y; Ozeki S; Yoshikawa K; Saga S; Takahashi T
    J Immunol; 2001 Jul; 167(2):759-64. PubMed ID: 11441080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.